Tag: Deinove
Deinove: End clap for the biotech Deinove, which will be delisted after its liquidation
(BFM Bourse) – In receivership since November, the Montpellier commercial court ordered the judicial liquidation of the Hérault biotech. The Deinove share will soon be delisted. Curtain down for Deinove.…
Deinove: judicial liquidation, cancellation in sight – 01/25/2023 at 12:25
(CercleFinance.com) – Deinove announced on Wednesday that the Commercial Court of Montpellier had rendered a judgment confirming the conversion of the receivership proceedings, initiated last November, into judicial liquidation. No…
Judicial liquidation of Deinove
Through Olivier Cheilan Published on 01/24/2023 at 6:01 p.m. Photo credit © Deinove …
Deinove provides an update on the receivership procedure
By Hector Chaunu Published on 16/12/2022 at 6:20 p.m. Photo credit © ChaunuPictures …
In cessation of payment, Deinove requests receivership
The biotech has requested the opening of receivership proceedings and is looking for investors to continue its activity. In cessation of payment, Deinove requests receivership | Photo credits: Deinove Deepening…
Deinove requested the opening of a receivership procedure
By Olivier Cheilan Published on 28/10/2022 at 6:15 p.m. Photo credit © Deinove …
Deinove: reduction of annual net loss
(CercleFinance.com) – Deinove publishes a net result of -7.0 million euros for the past year, against -7.3 million in 2020, mainly thanks to the 12% reduction in operating expenses to…
Deinove: reduction in annual net loss – 04/11/2022 at 14:03
(CercleFinance.com) – Deinove publishes a net result of -7.0 million euros for the past year, against -7.3 million in 2020, mainly thanks to the 12% reduction in operating expenses to…
Deinove slightly reduces its net loss in 2021 – 04/08/2022 at 18:10
(AOF) – Deinove has announced that it has received a favorable opinion from the DSMB and is continuing the Phase II trial evaluating DNV3837 in Clostridioides difficile infections. The company…
Deinove receives a favorable opinion for a phase II study
The independent monitoring and follow-up committee in charge of the phase II study developed by Deinove in the context of the fight against Clostridioides difficile infections, caused by an intestinal…